Volume 27, Issue 11 pp. 1159-1174
Original Article

A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation

Stephen O'Neill

Corresponding Author

Stephen O'Neill

MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK

Correspondence

Stephen O'Neill MB, BCh, BAO, MSc, MRCSEd, AFHEA, MAcadMEd, MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Chancellor's Building, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK.

Tel.: 0044-7849592113;

fax: 0044-1312429451;

e-mail: [email protected]

Search for more papers by this author
Amanda Roebuck

Amanda Roebuck

MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK

Search for more papers by this author
Emily Khoo

Emily Khoo

MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK

Search for more papers by this author
Stephen J. Wigmore

Stephen J. Wigmore

MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK

Search for more papers by this author
Ewen M. Harrison

Ewen M. Harrison

MRC Centre for Inflammation Research, Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK

Search for more papers by this author
First published: 22 July 2014
Citations: 139
Conflicts of interest
The authors have declared no conflicts of interest.

Summary

Donation after cardiac death (DCD) liver transplantation is increasingly common but concerns exist over the development of biliary complications and ischemic cholangiopathy (IC). This study aimed to compare outcomes between DCD and donation after brain death (DBD) liver grafts. Studies reporting on post-transplantation outcomes after Maastricht category III DCD liver transplantation were screened for inclusion. Odds ratios (OR) with 95% confidence intervals were produced using random-effects models for the incidence of biliary complications, IC, graft and recipient survival. Meta-regression was undertaken to identify between-study predictors of effect size for biliary complications and IC. PROSPERO Record: CRD42012002113. Twenty-five studies with 62 184 liver transplant recipients (DCD = 2478 and DBD = 59 706) were included. In comparison with DBD, there was a significant increase in biliary complications [OR = 2.4 (1.9, 3.1); P < 0.00001] and IC [OR = 10.5 (5.7, 19.5); P < 0.00001] following DCD liver transplantation. In comparison with DBD, at 1 year [OR = 0.7 (0.5, 0.8); P = 0.0002] and 3 years [OR = 0.6 (0.5, 0.8); P = 0.001], there was a significant decrease in graft survival following DCD liver transplantation. At 1 year, there was also a nonsignificant decrease [OR = 0.8 (0.6, 1.0); P = 0.08] and by 3 years a significant decrease [OR = 0.7 (0.5, 1.0); P = 0.04] found in recipient survival following DCD liver transplantation. Eleven factors were entered into meta-regression models, but none explained the variability in effect size between studies. DCD liver transplantation is associated with an increase in biliary complications, IC, graft loss and mortality. Significant unexplained differences in effect size exist between centers.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.